Cyclerion Therapeutics (CYCN) Revenue (2019 - 2025)

Cyclerion Therapeutics has reported Revenue for 6 years, with the latest figure at $875000.0 in Q3 2025.

• On a quarterly basis, Revenue rose 351.03% year-over-year to $875000.0 in Q3 2025; TTM through Sep 2025 was $2.9 million, a 1371.65% increase from a year earlier, with the FY2024 full-year figure at $2.0 million, changed N/A from the prior year.
• Revenue was $875000.0 for Q3 2025 at Cyclerion Therapeutics, up from $93000.0 in the prior quarter.
• The five-year high for Revenue was $3.0 million in Q2 2021, with the low at $62000.0 in Q1 2021.
• Average Revenue over 4 years is $728090.9, with a median of $348000.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Revenue slumped 93.89% in 2021, then jumped 1046.77% in 2022.
• Over 4 years, Revenue stood at $533000.0 in 2021, then sank by 42.59% to $306000.0 in 2022, then surged by 490.2% to $1.8 million in 2024, then slumped by 51.55% to $875000.0 in 2025.
• The last three Revenue figures came in at $875000.0 (Q3 2025), $93000.0 (Q2 2025), and $81000.0 (Q1 2025), per Business Quant data.